On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - $18.34 /
-12.19 (-39.93%) - 02/01/23
- Xometry, Gravity Climate announce initiative to reduce carbon footprints
- 11/02/22
- Xometry CEO sells $1.2M in common stock
- 10/05/22
- Xometry CEO sells $1.17M in common stock
- 10/03/22
- Xometry appoints Matt Leibel as CTO, Brendan Sterne as CPO
- 03/01/23
- Wendy's sees FY23 CapEx $75M-$85M
- 03/01/23
- Wendy's announces plan to redesign organizational structure
- 03/01/23
- Wendy's reports Q4 U.S. systemwide sales growth of 7.2%
- 03/01/23
- Wendy's reports Q4 U.S. same-restaurant sales growth 5.9%
- 02/27/23
- Tesla temporarily halts FSD beta software installations until recall addressed
- 02/24/23
- SEC says Elon Musk still needs lawyer to approve tweets
- 02/22/23
- Tesla to announce move to 'California Engineering Headquarters'
- 02/22/23
- Watchdog decides against fine after Tesla makes changes to security cameras
- $145.61 /
+23.42 (+19.17%) - 02/17/23
- Sarepta announces first patient dosed in SRP-9003-102 study
- 02/13/23
- Soros Fund buys Horizon Therapeutics, exits BNY Mellon in Q4
- 01/05/23
- Catalent, Sarepta expand commercial collaboration with deal for DMD candidate
- 11/28/22
- Sarepta announces FDA grants priority review for SRP-9001 BLA
- 01/31/23
- Spotify rises 9.8%
- 01/31/23
- Spotify reports Q4 MAUs up 20% y/y to 489M
- 01/26/23
- Spotify tweets 'everything's looking much better now'
- 01/26/23
- Spotify says 'something's not quite right,' company investigating
- 02/10/23
- Berkshire Grey confirms receipt of indication of interest from SoftBank Group
- 02/28/23
- Rivian Automotive down 6% following quarterly report
- 02/28/23
- Rivian Automotive sees 50,000 vehicles produced in 2023
RETA Reata Pharmaceuticals - $93.33 /
+62.165 (+199.50%) - 02/28/23
- Reata Pharmaceuticals trading resumes
- 02/28/23
- Reata Pharmaceuticals announces FDA approval of SKYCLARYS
- 02/28/23
- Reata Pharmaceuticals trading halted, news pending
- 02/28/23
- Reata Pharmaceuticals up 19% on omaveloxolone PDUFA date
- 01/29/23
- Philip Morris announces agreement to extend, deepen collaboration with KT&G
- 01/26/23
- FDA authorizes three new Marlboro heated tobacco products
- 01/22/23
- Fly Intel: Top five weekend stock stories
- 01/08/23
- Fly Intel: Top five weekend stock stories
- 02/14/23
- Nelson Peltz's Trian buys Disney, cuts Sysco in Q4
- 01/19/23
- Procter & Gamble says 'on track' to deliver FY23 guidance
- 01/19/23
- Procter & Gamble says Q2 growth broad based across business units
- 01/19/23
- Procter & Gamble reports Q2 gross margin down 160 bps vs. a year ago
- 02/28/23
- Novavax falls 26% to $6.80 after Q4 results miss estimates
- 02/28/23
- Novavax says 'substantial doubt exists' on ability to continue as going concern
- 02/23/23
- SEC charges Stiles cousins for insider trading in Kodak stock
- 02/13/23
- Novavax, U.S. government extend partnership
- 03/01/23
- Nerdy rises 29.9%
- 03/01/23
- Nerdy rises 25.1%
- 03/01/23
- Nerdy rises 21.9%
- 02/03/23
- Nerdy jumps after Varsity Tutors rolls out ChatGPT integration
- 03/01/23
- Xbox exclusive game 'Hi-Fi Rush' achieves 2M players since January release
- 02/28/23
- Microsoft debuts new AI-powered Bing to Windows 11 taskbar
- 02/26/23
- Fly Intel: Top five weekend stock stories
- 02/23/23
- Warner Bros. says 'Hogwarts Legacy' sells over 12M units in first two weeks
- 02/23/23
- Marqeta appoints Crystal Sumner as Chief Legal Officer
- 01/30/23
- Marqeta acquires Power Finance for $223M cash plus $52M milestone
- 01/26/23
- Marqeta names Simon Khalaf as CEO
- 12/07/22
- Marqeta integrates with Mastercard Track Instant Pay virtual card solution
- 02/28/23
- Monster Beverage announces 2-for-1 split, effective March 28
- 11/03/22
- Monster Beverage announces new $500M share repurchase program
- 10/27/22
- MSG Sports, MSG Entertainment enter marketing partnership with Monster Energy
- 10/10/22
- VPX Sports, maker of Bang Energy drinks, seeks Chapter 11 bankruptcy protection
- 02/27/23
- Mark Zuckerberg announces new team at Meta working on A.I. products
- 02/27/23
- Entravision named authorized sales partner of Meta Platforms in Mongolia
- 02/21/23
- Meta Platforms COO sells $2.27M in common stock
- 02/20/23
- Fly Intel: Top five weekend stock stories
- $194.32 /
-11.35 (-5.52%) - 03/01/23
- Lowe's announces national partnership with Hubbell
- 03/01/23
- Lowe's CEO: Consumers opting to upgrade existing homes
- 03/01/23
- Lowe's sees FY23 operating margin 13.6%-13.8%
- 03/01/23
- Lowe's: Long-term outlook for home improvement remains strong
- 02/28/23
- Kohl's appoints Dave Alves COO
- 02/09/23
- Kohl's names Nick Jones Chief Merchandising and Digital Officer
- 02/02/23
- Kohl's names Tom Kingsbury as CEO
- 11/14/22
- Starboard takes stake in Wix.com, exits Elanco Animal Health
- 02/22/23
- Intel provides update on effort to optimize cost structure
- 02/22/23
- Intel reduces quarterly dividend to 12.5c per share
- 02/14/23
- Greenlight buys Tenet, exits Intel in Q4
- 02/15/23
- HP announces Z by HP workstation desktop lineup
- 01/04/23
- HP Inc. announces products, solutions to recharge hybrid experiences
- 12/14/22
- HP Inc. director Banerji sells $511K in company shares
- 12/01/22
- VerifyMe and HP Indigo enter into five-year agreement expansion.
- 03/01/23
- Honda reports February U.S. sales down 1.4% to 83,247 units
- 02/21/23
- EU passenger car registrations up 11.3% in January
- 02/03/23
- Honda issues 'Do Not Drive' warning for certain 2001-2003 Acura, Honda vehicles
- 02/01/23
- Honda reports January U.S. sales up 14.3% to 84,514 units
- 02/21/23
- General Motors subsidiary, Tawazun Council sign cooperation agreement
- 02/15/23
- GM, EVgo to build 2,000 high power fast chargers along American highways
- 02/15/23
- White House announces progress for national network of EV chargers
- 03/01/23
- Figs falls -25.2%
- 03/01/23
- Figs falls -19.6%
- 03/01/23
- Figs falls -23.8%
- 02/22/23
- Figs says Strategic Partners' litigation against company is over
- $22.80 /
-14.57 (-38.99%) - 11/10/22
- National Vision reports Q3 comparable store sales growth (8.0%)
- $16.28 /
+3.625 (+28.66%) - 03/01/23
- B&G Foods rises 27.4%
- 03/01/23
- B&G Foods rises 27.6%
- 03/01/23
- B&G Foods rises 18.9%
- 02/01/23
- B&G Foods issues voluntary allergy alert for Back to Nature fudge cookies
- 03/01/23
- Amplify Energy reaches $96.5M settlement with shipping companies
- 12/13/22
- Amplify Energy: Revolving credit facility extended, borrowing base redetermined
- $83.36 /
-10.865 (-11.53%) - 02/07/23
- Ambarella CV3-AD family selected by Hyperview
- 01/04/23
- Ambarella, Kodiak Robotics announce integration partnership for CV2AQ AI SoC
- 01/03/23
- Ambarella, Autobrains and Seeing Machines to offer three safety systems in one
- 12/06/22
- Ambarella announces first centralized 4D imaging radar architecture
- 03/01/23 BofA
- HP Inc. price target lowered to $26 from $27 at BofA
- 03/01/23 JPMorgan
- HP Inc. price target raised to $30 from $27 at JPMorgan
- 02/21/23 Morgan Stanley
- HP Inc. price target raised to $28 from $24 at Morgan Stanley
- 01/09/23 Bernstein
- HP Inc. price target lowered to $29 from $30 at Bernstein
- $194.32 /
-11.35 (-5.52%) - 03/01/23 Baird
- Lowe's price target lowered to $235 from $250 at Baird
- 03/01/23 Roth MKM
- Lowe's price target lowered to $200 from $205 at Roth MKM
- 02/07/23 Barclays
- Barclays sees a 'reset' in U.S. retail but 'not a recession yet'
- 02/07/23 Barclays
- Lowe's initiated with an Equal Weight at Barclays
- 03/01/23 Credit Suisse
- Credit Suisse lowers Kohl's price target to $27 following quarterly results
- 02/02/23 Guggenheim
- Kohl's price target lowered to $38 from $42 at Guggenheim
- 01/30/23 Goldman Sachs
- Kohl's initiated with a Sell at Goldman Sachs
- 01/03/23 JPMorgan
- Kohl's price target lowered to $26 from $33 at JPMorgan
- 03/01/23 B. Riley
- B. Riley downgrades 'show-me story' Novavax amid liquidity challenge
- 03/01/23 B. Riley
- Novavax downgraded to Neutral from Buy at B. Riley
- 02/17/23 B. Riley
- Novavax price target lowered to $29 from $37 at B. Riley
- 02/13/23 H.C. Wainwright
- H.C. Wainwright reiterates Top Pick Buy on Novavax after partnership extension
- 02/28/23 JPMorgan
- Honda upgraded to Overweight from Neutral at JPMorgan
- 03/03/22 Morgan Stanley
- Other legacy automakers may follow Ford's lead, says Morgan Stanley
- 03/01/23 UBS
- UBS upgrades Philip Morris to Buy into heated tobacco launches
- 03/01/23 UBS
- Philip Morris upgraded to Buy from Neutral at UBS
- 02/02/23 Morgan Stanley
- Philip Morris price target raised to $118 from $109 at Morgan Stanley
- 01/25/23 Goldman Sachs
- Philip Morris upgraded to Buy from Neutral at Goldman Sachs
- $145.61 /
+23.42 (+19.17%) - 03/01/23 RBC Capital
- Sarepta price target raised to $226 from $195 at RBC Capital
- 03/01/23 Oppenheimer
- Sarepta price target raised to $180 from $150 at Oppenheimer
- 03/01/23 Credit Suisse
- Sarepta price target raised to $144 from $137 at Credit Suisse
- 03/01/23 Needham
- Needham ups Sarepta target to $200, adds to Conviction list
- 03/01/23 Redburn
- Spotify upgraded to Buy from Neutral at Redburn
- 02/06/23 Wells Fargo
- Spotify upgraded to Overweight from Equal Weight at Wells Fargo
- 02/06/23 Atlantic Equities
- Spotify upgraded to Overweight from Neutral at Atlantic Equities
- 02/01/23 Truist
- Spotify price target raised to $132 from $115 at Truist
- 03/02/23 Barclays
- Marqeta price target lowered to $6 from $10 at Barclays
- 03/01/23 DA Davidson
- Marqeta price target lowered to $5.00 from $7.25 at DA Davidson
- 03/01/23 Credit Suisse
- Marqeta price target lowered to $8 from $13.50 at Credit Suisse
- 03/01/23 JPMorgan
- Marqeta downgraded to Neutral from Overweight at JPMorgan
- 03/01/23 UBS
- Procter & Gamble upgraded to Buy from Neutral at UBS
- 02/16/23 Citi
- Citi launches beverage, personal space with six buys, two sells
- 02/16/23 Citi
- Procter & Gamble initiated with a Buy at Citi
- 01/20/23 Stifel
- Procter & Gamble price target raised to $147 from $139 at Stifel
- 02/24/23 BofA
- GM should be bought, not sold, on truck production cut, says BofA
- 02/15/23 Needham
- GlobalFoundries price target raised to $80 from $72 at Needham
- 02/14/23 Barclays
- Barclays starts autos and mobility sector, says Tesla stands out
- 02/14/23 Barclays
- General Motors initiated with an Equal Weight at Barclays
- 02/24/23 Wedbush
- Microsoft price target raised to $290 from $280 at Wedbush
- 02/16/23 Deutsche Bank
- Deutsche upgrades Activision to Buy, says best risk/reward in gaming
- 02/13/23 Morgan Stanley
- Morgan Stanley sees 5 quarters of accelerating EPS growth at Microsoft after Q2
- 02/13/23 BofA
- BofA starts Okta at Underperform with 'no positive catalysts in sight'
- 03/01/23 Raymond James
- Intel resumed with an Outperform at Raymond James
- 02/23/23 Morgan Stanley
- Intel upgraded to Equal Weight from Underweight at Morgan Stanley
- 02/22/23 Truist
- Intel's dividend cut 'not terribly surprising,' says Truist
- 02/22/23 Oppenheimer
- Intel management remains in 'prove-it mode,' says Oppenheimer
- 02/21/23 BofA
- BofA sees 12M potential subscriber opportunity for Meta Verified
- 02/13/23 BofA
- BofA sees room for additional efficiencies at Meta
- 02/10/23 Tigress Financial
- Meta Platforms price target raised to $285 from $260 at Tigress Financial
- 02/08/23 Loop Capital
- Meta Platforms price target raised to $188 from $165 at Loop Capital
- 02/28/23 Jefferies
- SoftBank Group upgraded to Hold from Underperform at Jefferies
- 12/06/22 JPMorgan
- SoftBank Group downgraded to Neutral from Overweight at JPMorgan
- 11/29/22 Citi
- SoftBank Group downgraded to Neutral from Buy at Citi
- 11/14/22 Jefferies
- SoftBank Group downgraded to Underperform from Hold at Jefferies
- 03/02/23 Citi
- Lack of details at Tesla event likely a letdown, says Citi
- 03/02/23 Wells Fargo
- Wells Fargo expects Tesla stock to trade down following Investor Day
- 02/28/23 Wedbush
- Wedbush expects key updates on expansion/capacity plans at Tesla investor day
- 02/27/23 Barclays
- Tesla investor day may be 'sell-the-news event,' says Barclays
RETA Reata Pharmaceuticals - $93.33 /
+62.165 (+199.50%) - 03/01/23 SVB Securities
- Reata Pharmaceuticals price target raised to $75 from $35 at SVB Securities
- 03/01/23 Stifel
- Reata Pharmaceuticals price target raised to $105 from $75 at Stifel
- 03/01/23 Baird
- Reata Pharmaceuticals price target raised to $85 from $40 at Baird
- 03/01/23 Cantor Fitzgerald
- Reata Pharmaceuticals price target raised to $121 from $61 at Cantor Fitzgerald
- 03/01/23 Cantor Fitzgerald
- Nerdy price target raised to $6 from $4 at Cantor Fitzgerald
- 12/07/22 Cantor Fitzgerald
- Udemy named new 'top pick' in software at Cantor Fitzgerald
- 11/15/22 Canaccord
- Nerdy price target lowered to $5 from $6 at Canaccord
- 10/18/22 Barclays
- Nerdy price target lowered to $2.50 from $4 at Barclays
- $16.28 /
+3.625 (+28.66%) - 12/01/22 Consumer Edge
- B&G Foods downgraded to Underweight from Equal Weight at Consumer Edge
- 11/11/22 RBC Capital
- B&G Foods price target lowered to $16 from $24 at RBC Capital
- 11/10/22 BMO Capital
- B&G Foods price target lowered to $14 from $21 at BMO Capital
- 08/08/22 BMO Capital
- B&G Foods price target lowered to $21 from $29 at BMO Capital
- 10/28/22 Roth MKM
- Amplify Energy upgraded to Buy from Neutral at Roth Capital
- 10/28/22 Roth MKM
- Amplify Energy upgraded to Buy from Neutral at Roth Capital
- $18.34 /
-12.19 (-39.93%) - 03/02/23 JPMorgan
- Xometry downgraded to Neutral from Overweight at JPMorgan
- 03/02/23 RBC Capital
- Xometry downgraded to Sector Perform from Outperform at RBC Capital
- 01/31/23 Craig-Hallum
- Xometry initiated with a Buy at Craig-Hallum
- 12/14/22 Lake Street
- Xometry initiated with a Sell at Lake Street
- 01/31/23 TD Cowen
- Figs price target raised to $11 from $6 at Cowen
- 11/17/22 Oppenheimer
- Figs price target lowered to $12 from $22 at Oppenheimer
- 11/14/22 Barclays
- Figs price target lowered to $6 from $9 at Barclays
- 11/11/22 Raymond James
- Figs downgraded to Outperform from Strong Buy at Raymond James
- $22.80 /
-14.57 (-38.99%) - 03/02/23 UBS
- National Vision price target lowered to $31 from $50 at UBS
- 03/02/23 Wells Fargo
- National Vision price target lowered to $30 from $44 at Wells Fargo
- 03/02/23 Barclays
- National Vision price target lowered to $25 from $43 at Barclays
- 01/17/23 Morgan Stanley
- National Vision downgraded to Equal Weight from Overweight at Morgan Stanley
- 03/01/23 RBC Capital
- Rivian Automotive price target lowered to $28 from $50 at RBC Capital
- 03/01/23 DA Davidson
- Rivian Automotive price target lowered to $16 from $23 at DA Davidson
- 03/01/23 Canaccord
- Rivian Automotive price target lowered to $40 from $55 at Canaccord
- 03/01/23 Wedbush
- Rivian Automotive price target lowered to $25 from $37 at Wedbush
- 03/01/23 BMO Capital
- Monster Beverage price target raised to $105 from $97 at BMO Capital
- 03/01/23 Truist
- Monster Beverage price target raised to $120 from $100 at Truist
- 03/01/23 Citi
- Monster Beverage price target lowered to $118 from $121 at Citi
- 02/22/23 Stifel
- Stifel buyers on any post-Q4 weakness in Monster Beverage
- 01/17/23 Truist
- Wendy's price target raised to $28 from $27 at Truist
- 01/16/23 Deutsche Bank
- Wendy's downgraded to Hold from Buy at Deutsche Bank
- 01/13/23 Evercore ISI
- Wendy's downgraded to In Line at Evercore, prefers share gainers
- 01/13/23 Evercore ISI
- Wendy's downgraded to In Line from Outperform at Evercore ISI
- $83.36 /
-10.865 (-11.53%) - 03/01/23 Roth MKM
- Roth MKM downgrades Ambarella to Neutral following weaker guidance
- 03/01/23 Imperial Capital
- Ambarella downgraded to In-Line from Outperform at Imperial Capital
- 03/01/23 Craig-Hallum
- Ambarella price target lowered to $110 from $120 at Craig-Hallum
- 03/01/23 Susquehanna
- Ambarella price target raised to $100 from $96 at Susquehanna
- $18.34 /
-12.19 (-39.93%) - 03/01/23
- Xometry sees FY23 revenue $470M-$480M, consensus $515.87M
- 03/01/23
- Xometry sees Q1 revenue $100M-$102M, consensus $112.79M
- 03/01/23
- Xometry reports Q4 adjusted EPS (29c), consensus (23c)
- 11/10/22
- Xometry sees Q4 revenue $104M-$106M, consensus $116.11M
- 03/01/23
- Wendy's sees FY23 adjusted EPS 95c-$1.00, consensus $1.00
- 03/01/23
- Wendy's reports Q4 adjusted EPS 22c, consensus 20c
- 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 01/25/23
- Notable companies reporting after market close
- 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- 10/19/22
- Notable companies reporting after market close
- $145.61 /
+23.42 (+19.17%) - 02/28/23
- Sarepta reports Q4 EPS ($1.24), consensus ($1.35)
- 01/09/23
- Sarepta expects to exceed FY22 guidance for net product revenues
- 11/02/22
- Sarepta reports Q EPS (80c), consensus (1.43)
- 01/31/23
- Spotify sees Q1 revenue EUR 3.1B, gross margin 24.9%
- 01/31/23
- Spotify reports Q4 EPS (EUR 1.40) vs. (EUR 0.20) last year
- 10/25/22
- Spotify reports Q3 Operating loss EUR (228M) vs. profit EUR 75M prior
- 02/28/23
- Rivian Automotive reports Q4 adjusted EPS ($1.73), consensus ($1.94)
- 02/02/23
- Amazon reports Q4 EPS 3c with Rivian loss, consensus 17c
- 11/09/22
- Rivian Automotive reports Q3 adjusted EPS ($1.57), consensus ($1.82)
RETA Reata Pharmaceuticals - $93.33 /
+62.165 (+199.50%) - 11/08/22
- Reata Pharmaceuticals reports Q3 non-GAAP EPS ($1.47), consensus ($2.18)
- 02/09/23
- Philip Morris sees FY23 adjusted EPS, ex-currency $6.40-$6.52, consensus $5.90
- 02/09/23
- Philip Morris sees FY23 currency-neutral adjusted EPS growth of 7%-9%
- 02/09/23
- Philip Morris reports Q4 adjusted EPS ex-RU/UA $1.23, consensus $1.24
- 02/08/23
- Notable companies reporting before tomorrow's open
- 01/19/23
- Procter & Gamble raises FY23 sales growth outlook
- 01/19/23
- Procter & Gamble reports Q2 core EPS $1.59, consensus $1.59
- 01/18/23
- Notable companies reporting before tomorrow's open
- 02/28/23
- Novavax reports Q4 EPS ($2.28), consensus (92c)
- 12/14/22
- Novavax reaffirms FY22 revenue guidance approximately $2B, consensus $2.1B
- 11/08/22
- Novavax sees FY22 revenue $2B, consensus $2.04B
- 11/08/22
- Novavax reports Q3 EPS ($2.15) vs. ($4.31) last year
- 02/28/23
- Nerdy sees Q1 revenue $45M-$47M, consensus $47.74M
- 02/28/23
- Nerdy sees FY23 revenue $190M-$200M, consensus $195.57M
- 02/28/23
- Nerdy reports Q4 revenue $41.8M, consensus $39.93M
- 11/14/22
- Nerdy sees FY22 revenue $160M-$162M, consensus $167.8M
- 01/24/23
- Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29
- 01/24/23
- Notable companies reporting after market close
- 10/25/22
- Microsoft sees FX decreasing total revenue growth by 5% in FY23
- 10/25/22
- Microsoft reports Q1 EPS $2.35, consensus $2.30
- 02/28/23
- Marqeta sees Q1 net revenue growth 26%-28%, consensus $214.08M
- 02/28/23
- Marqeta reports Q4 EPS (5c), consensus (9c)
- 11/09/22
- Marqeta sees Q4 revenue up 29%-31%, consensus $191M
- 02/28/23
- Monster Beverage reports Q4 EPS 57c, consensus 63c
- 11/03/22
- Monster Beverage reports Q3 EPS 60c, consensus 59c
- 11/03/22
- Notable companies reporting after market close
- 02/01/23
- Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B
- 02/01/23
- Meta Platforms reports Q4 EPS $1.76, consensus $2.22
- 02/01/23
- Notable companies reporting after market close
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- $194.32 /
-11.35 (-5.52%) - 03/01/23
- Lowe's sees Q1 sales comps below FY guidance range
- 03/01/23
- Lowe's sees FY23 EPS $13.60-$14.00, consensus $13.73
- 03/01/23
- Lowe's reports Q4 adjusted EPS $2.28, consensus $2.21
- 02/28/23
- Notable companies reporting before tomorrow's open
- 03/01/23
- Kohl's sees FY23 EPS $2.10-$2.70, consensus $2.99
- 03/01/23
- Kohl's reports Q4 adjusted EPS ($2.49), consensus 98c
- 02/22/23
- Intel backs Q1 EPS view (15c), consensus (15c)
- 02/16/23
- Tower Semiconductor not providing Q1 revenue guidance
- 01/26/23
- Intel sees Q1 EPS (15c), consensus 24c
- 01/26/23
- Intel reports Q4 EPS 10c, consensus 20c
- 02/28/23
- HP Inc. sees FY23 EPS $3.20-$3.60, consensus $3.29
- 02/28/23
- HP Inc. sees Q2 EPS 73c-83c, consensus 76c
- 02/28/23
- HP Inc. reports Q1 EPS 75c, consensus 74c
- 02/28/23
- Notable companies reporting after market close
- 02/10/23
- Honda lowers 2023 revenue view to Y17.25T from Y17.4T
- 02/10/23
- Honda reports Q3 EPS Y144.49 vs. Y112.42 last year
- 11/09/22
- Honda raises 2023 revenue view by Y650B to Y17.4T
- 11/09/22
- Honda reports Q2 EPS Y110.85 vs. Y96.56 last year
- 01/31/23
- General Motors sees FY23 adjusted EPS $6.00-$7.00, consensus $5.81
- 01/31/23
- General Motors reports Q4 adjusted EPS $2.12, consensus $1.69
- 01/30/23
- Notable companies reporting before tomorrow's open
- 02/28/23
- Figs sees FY23 revenue mid-single digit growth, consensus $560.64M
- 02/28/23
- Figs reports Q4 adjusted EPS 5c, consensus 1c
- 11/10/22
- Figs sees FY22 revenue $495M, consensus $511.93M
- 11/10/22
- Figs reports Q3 EPS 2c, consensus 2c
- $22.80 /
-14.57 (-38.99%) - 03/01/23
- National Vision sees FY23 adjusted EPS 42c-60c, consensus 98c
- 03/01/23
- National Vision reports Q4 adjusted EPS (8c), consensus (2c)
- 11/10/22
- National Vision backs FY22 adjusted EPS view 65c-77c, consensus 73c
- 11/10/22
- National Vision reports Q3 adjusted EPS 15c, consensus 13c
- $16.28 /
+3.625 (+28.66%) - 02/28/23
- B&G Foods sees FY23 adjusted EPS 95c-$1.15, consensus $1.02
- 02/28/23
- B&G Foods reports Q4 adjusted EPS 40c, consensus 22c
- 11/09/22
- B&G Foods backs FY22 revenue view $2.1B-$2.14B, consensus $2.14B
- 11/09/22
- B&G Foods reports Q3 adjusted EPS 31c, consensus 31c
- $83.36 /
-10.865 (-11.53%) - 02/28/23
- Ambarella sees Q1 revenue $60M-$64M, consensus $77.14M
- 02/28/23
- Ambarella reports Q4 adjusted EPS 23c, consensus 14c
- 12/01/22
- Ambarella sees Q4 revenue $81M-$85M, consensus $85.39M
- 12/01/22
- Ambarella reports Q3 EPS 24c, consensus 20c
|